Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Implementing Hazardous Substance Training for Emergency Responders, Announcement Number: OH-02-009

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Implementing Hazardous Start Printed Page 45524Substance Training for Emergency Responders, RFA OH-02-009.

Times and Dates: 8 a.m.-8:30 a.m., July 24, 2002 (Open); 8:40 a.m.-5 p.m., July 24, 2002 (Closed).

Place: Brazilian Court Hotel, 301 Australian Avenue, Palm Beach, FL 33480, phone (561) 655-7740.

Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Deputy Director for Program Management, CDC, pursuant to Public Law 92-463.

Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to RFA OH-02-009.

Contact Person for More Information: Roger Rosa, Ph.D., Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 751H Hubert Humphrey Building, Washington, DC 20201, telephone (202) 205-7856.

The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: July 2, 2002.

Joe Salter,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

End Signature End Preamble

[FR Doc. 02-17159 Filed 7-8-02; 8:45 am]

BILLING CODE 4163-19-P